Vernal keratoconjunctivitis

References

• ChengeBMakumyamviriAMKaimboWAKaimboDLa limbo-conjunctivite endemique des tropiques a Lubumbashi, Republique Democratique du Congo. [Tropical endemic limbo-conjunctivitis in Lúbumbashi, Democratic Republic of the Congo]Bull Soc Belge Ophtalmol2003290916 French
   Google Scholar
• DahanEAppelRVernal keratoconjunctivitis in the black child and its response to therapyBr J Ophthalmol198367106886926412738
   PubMed Web of Science ®Google Scholar
• BoniniSBoniniSLambiaseAVernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followupOphthalmology200010761157116310857837
   PubMed Web of Science ®Google Scholar
• SabooUSJainMReddyJCSangwanVSDemographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in IndiaIndian J Ophthalmol201361948648924104706
   PubMed Web of Science ®Google Scholar
• BoniniSCoassinMAronniSLambiaseAVernal keratoconjunctivitisEye200418434535115069427
   PubMed Web of Science ®Google Scholar
• LeonardiAVernal keratoconjunctivitis: pathogenesis and treatmentProg Retin Eye Res200221331933912052387
   PubMed Web of Science ®Google Scholar
• MetzDPHingoraniMCalderVLBuckleyRJLightmanSLT-cell cytokines in chronic allergic eye diseaseJ Allergy Clin Immunol19971006 Pt 18178249438492
   PubMed Web of Science ®Google Scholar
• LeonardiALazzariniDBortolottiMPiliegoFMidenaEFregonaICorneal confocal microscopy in patients with vernal keratoconjunctivitisOphthalmology2012119350951522176802
   PubMed Web of Science ®Google Scholar
• Al-HakamiAMAl-AmriAAbdulrahimIHamidMEIs there is an association between the presence of Staphylococcus species and occurrence of vernal keratoconjunctivitis?Saudi J Ophthalmol201529425525826586974
   PubMedGoogle Scholar
• SacchettiMLambiaseAMantelliFDeligianniVLeonardiABoniniSTailored approach to the treatment of vernal keratoconjunctivitisOphthalmology201011771294129920382430
   PubMed Web of Science ®Google Scholar
• MannisMJHollandEJCornea2nd ed1EdinburghElsevier2017
   Google Scholar
• LeonardiABogackaEFauquertJLOcular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surfaceAllergy201267111327133722947083
   PubMed Web of Science ®Google Scholar
• MantelliFSantosMSPetittiTSystematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitisBr J Ophthalmol200791121656166117588996
   PubMed Web of Science ®Google Scholar
• BruijnzeelPLWarringaRAKokPTKreuknietJInhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycateBr J Pharmacol19909947988022163279
   PubMed Web of Science ®Google Scholar
• CaldwellDRVerinPHartwich-YoungRMeyerSMDrakeMMEfficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitisAm J Ophthalmol199211366326371598953
   PubMed Web of Science ®Google Scholar
• HidaWTNogueiraDCSchaeferADantasPECDantasMCNComparação entre o uso tópico do fumarato de cetotifeno 0,025% e do cloridrato de olopatadina 0,1% no tratamento da ceratoconjuntivite primaveril. [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis]Arq Bras Oftalmol2006696851856 Portuguese17273679
   PubMedGoogle Scholar
• D’AngeloGLambiaseACortesMPreservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitisGraefes Arch Clin Exp Ophthalmol200324119219512644942
   PubMed Web of Science ®Google Scholar
• SharmaAGuptaRRamJGuptaATopical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitisIndian J Ophthalmol19974531771809475021
   PubMedGoogle Scholar
• KosrirukvongsPLuengchaichawangeCTopical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitisJ Med Assoc Thai200487219019715061303
   PubMedGoogle Scholar
• LeonardiAManagement of vernal keratoconjunctivitisOphthalmol Ther201322738825135808
   PubMedGoogle Scholar
• DonnenfeldEPflugfelderSCTopical ophthalmic cyclosporine: pharmacology and clinical usesSurv Ophthalmol200954332133819422961
   PubMed Web of Science ®Google Scholar
• PucciNCaputoRMoriFLong-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitisInt J Immunopathol Pharmacol201023386587120943058
   PubMed Web of Science ®Google Scholar
• OrayMTokerETear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapyCornea20133281149115423676782
   PubMed Web of Science ®Google Scholar
• TesseRSpadavecchiaLFanelliPTreatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 childrenPediatr Allergy Immunol2010212 pt 133033519840298
   PubMed Web of Science ®Google Scholar
• KiliçAGürlerBTopical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitisCan J Ophthalmol200641669369817224949
   PubMed Web of Science ®Google Scholar
• YücelOEUlusNDEfficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitisSingapore Med J201657950751026768065
   PubMed Web of Science ®Google Scholar
• ZhaiJGuJYuanJChenJTacrolimus in the treatment of ocular diseasesBioDrugs2011258910321443273
   PubMed Web of Science ®Google Scholar
• ChatterjeeSAgrawalDTacrolimus in corticosteroid-refractory vernal keratoconjunctivitisCornea20163511444144827310883
   PubMed Web of Science ®Google Scholar
• MiyazakiDFukushimaAOhashiYSteroid-sparing effect of 0.1% Tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseasesOphthalmology2017124328729428017421
   PubMed Web of Science ®Google Scholar
• ZanjaniHAminifardMNGhafourianAComparative evaluation of tacrolimus versus interferon alpha-2b eye drops in the treatment of vernal keratoconjunctivitis: a randomized, double-masked studyCornea201736667567828399035
   PubMed Web of Science ®Google Scholar
• OccasiFDuseMNebbiosoMVernal keratoconjunctivitis treated with omalizumab: a case seriesPediatr Allergy Immunol201728550350528543949
   PubMed Web of Science ®Google Scholar
• MahdyRARNadaWMMareiAASubcutaneous allergen-specific immunotherapy versus topical treatment in vernal keratoconjunctivitisCornea201231552552822314814
   PubMed Web of Science ®Google Scholar
• GuoPKheirkhahAZhouW-WQinLShenX-LSurgical resection and amniotic membrane transplantation for treatment of refractory giant papillae in vernal keratoconjunctivitisCornea201332681682023086371
   PubMed Web of Science ®Google Scholar
• FukudaKNishidaTOcular allergic inflammation: interaction between the cornea and conjunctivaCornea201029S62S6720935545
   PubMedGoogle Scholar
• NeumannEGutmannMJBlumenkrantzNMichaelsonICA review of four hundred cases of vernal conjunctivitisAm J Ophthalmol195947216617213617386
   PubMed Web of Science ®Google Scholar
• CameronJAShield ulcers and plaques of the cornea in vernal keratoconjunctivitisOphthalmology199510269859937777308
   PubMed Web of Science ®Google Scholar
• SangwanVSJainVVemugantiGKMurthySIVernal keratoconjunctivitis with limbal stem cell deficiencyCornea201130549149621598432
   PubMed Web of Science ®Google Scholar
• TabbaraKFOcular complications of vernal keratoconjunctivitisCan J Ophthalmol1999342889210321319
   PubMed Web of Science ®Google Scholar
• BackmanHRäisänenPHedmanLIncreased prevalence of allergic asthma from 1996 to 2006 and further to 2016 – results from three population surveysClin Exp Allergy201747111426143528608416
   PubMed Web of Science ®Google Scholar